Earnings report: Novo Nordisk cashes in on weight loss drug fever with better-than-expected results

This morning, pharmaceuticals company Novo Nordisk reported triumphant Q1 2024 financial results before markets opened. One of the more memorable highlights was certainly the fact that Novo Nordisk’s sales increased by 22% in Danish kroner (by 24% at constant exchange rates) to DKK 65.3 billion for the period.  Profits up by over a quarter Meanwhile, […]